Department of Research Pathology, MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA.
Department of Pathology, MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA.
Ann Diagn Pathol. 2019 Aug;41:14-23. doi: 10.1016/j.anndiagpath.2019.04.015. Epub 2019 May 5.
Spiradenoma and cylindroma are related sweat gland tumors. To delineate their histogenesis, gene profiles, and their potential drivers, we performed a whole-transcriptome sequencing analysis of fourteen samples of spiradenoma/cylindroma in comparison to normal samples. A total of 12 spiradenomas, 5 cylindromas, 3 hybrid spiradenomas/cylindromas and 2 adnexal carcinomas were included in this study. 1335 characteristic genes and transcripts expressed over all 14 spiradenoma/cylindroma tumors were identified, and two groups of expression profiles were observed. Highest upregulated top 7 gene signatures characterized benign tumors with developmental and differentiation related genes, and carcinomas with top 7 genes mainly related to signaling, reorganization and metabolism of membranes. Immunohistochemistry of protein expressions validated 4 upregulated genes (ODAM, HOXB13, MYB and SOX10) considered important and as potential biomarkers for spiradenomas and cylindromas. We further compared the transcriptome of eccrine adnexal tumors with the transcriptome of adenoid cystic carcinoma (ACC) to identify the overlapping genes that may indicate histogenesis. There were 36 specific genes overlapping between adnexal carcinomas and the epithelial-dominant subtype of ACC, and 27 specific genes overlapping benign adnexal tumors with the myoepithelial-dominant subtype of ACC, At this point there is no known specific biomarker to aid in the diagnosis of eccrine spiradenoma and cylindroma in small samples or biopsies within the context of morphological overlap with ACC. In conclusion, spiradenomas and cylindromas are characterized by overexpressed developmental genes, where LHX2 and activated WNT signaling possibly drive associated carcinomas.
汗管瘤和圆柱瘤是相关的汗腺肿瘤。为了阐明其组织发生、基因谱及其潜在驱动因素,我们对 14 例汗管瘤/圆柱瘤样本与正常样本进行了全转录组测序分析。本研究共纳入 12 例汗管瘤、5 例圆柱瘤、3 例混合汗管瘤/圆柱瘤和 2 例附属器癌。鉴定了所有 14 例汗管瘤/圆柱瘤肿瘤中表达的 1335 个特征基因和转录本,并观察到两组表达谱。上调最明显的前 7 个基因特征是良性肿瘤的发育和分化相关基因,而前 7 个基因的癌与信号、膜的重排和代谢有关。对蛋白表达的免疫组织化学验证了 4 个上调基因(ODAM、HOXB13、MYB 和 SOX10)被认为是汗管瘤和圆柱瘤的重要潜在生物标志物。我们进一步比较了外分泌附属器肿瘤和腺样囊性癌(ACC)的转录组,以鉴定可能提示组织发生的重叠基因。附属器癌与上皮占优势型 ACC 之间有 36 个特定重叠基因,良性附属器肿瘤与肌上皮占优势型 ACC 之间有 27 个特定重叠基因。目前还没有已知的特异性生物标志物可用于在与 ACC 形态学重叠的情况下,在小样本或活检中辅助诊断小汗腺汗管瘤和圆柱瘤。总之,汗管瘤和圆柱瘤的特征是过度表达发育基因,其中 LHX2 和激活的 WNT 信号可能驱动相关的癌。